<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7948368/table_2" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 2</label>
  <p>Ingenuity pathway analysis (IPA)</p>
 </caption>
 <thead>
  <tr>
   <th colspan="1" rowspan="1" id="0-0-.">col0</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td colspan="3">Top canonical pathways</td>
  </tr>
  <tr>
   <td> Name</td>
   <td>
    <i>p</i> value 
   </td>
   <td>Overlap</td>
  </tr>
  <tr>
   <td>  Altered T cell and B cell signalling in rheumatoid arthritis</td>
   <td>1.41E− 10</td>
   <td>17.3%, 14/81</td>
  </tr>
  <tr>
   <td>  TREM1 signalling</td>
   <td>2.53E− 10</td>
   <td>18.6%, 13/70</td>
  </tr>
  <tr>
   <td>  Dendritic cell maturation</td>
   <td>5.68E− 08</td>
   <td>9.5%, 16/169</td>
  </tr>
  <tr>
   <td>  Allograft rejection signalling</td>
   <td>1.39E− 07</td>
   <td>18.8%, 9/48</td>
  </tr>
  <tr>
   <td>  Communication between innate and adaptive immune cells</td>
   <td>2.06E− 07</td>
   <td>13.4%, 11/82</td>
  </tr>
  <tr>
   <td colspan="3">Top upstream regulators</td>
  </tr>
  <tr>
   <td> Upstream regulator</td>
   <td colspan="2">
    <i>p</i> value of overlap 
   </td>
  </tr>
  <tr>
   <td>  TGM2</td>
   <td colspan="2">4.66E− 15</td>
  </tr>
  <tr>
   <td>  CEBPA</td>
   <td colspan="2">1.16E− 08</td>
  </tr>
  <tr>
   <td>  CSF2</td>
   <td colspan="2">1.70E− 08</td>
  </tr>
  <tr>
   <td>  TNF</td>
   <td colspan="2">1.53E− 06</td>
  </tr>
  <tr>
   <td>  IRF4</td>
   <td colspan="2">2.33E− 06</td>
  </tr>
  <tr>
   <td colspan="3">Top diseases and disorders</td>
  </tr>
  <tr>
   <td> Name</td>
   <td>
    <i>p</i> value 
   </td>
   <td>Molecules</td>
  </tr>
  <tr>
   <td>  Immunological disease</td>
   <td>6.30E− 03 to 1.20E− 22</td>
   <td>151</td>
  </tr>
  <tr>
   <td>  Connective tissue disorders</td>
   <td>5.32E− 03 to 3.31E− 21</td>
   <td>81</td>
  </tr>
  <tr>
   <td>  Inflammatory disease</td>
   <td>6.18E− 03 to 3.31E− 21</td>
   <td>116</td>
  </tr>
  <tr>
   <td>  Skeletal and muscular disorders</td>
   <td>5.32E− 03 to 3.31E− 21</td>
   <td>106</td>
  </tr>
  <tr>
   <td>  Infectious diseases</td>
   <td>5.76E− 03 to 5.84E− 20</td>
   <td>76</td>
  </tr>
  <tr>
   <td colspan="3">Top molecular and cell functions</td>
  </tr>
  <tr>
   <td> Name</td>
   <td>
    <i>p</i> value 
   </td>
   <td>Molecules</td>
  </tr>
  <tr>
   <td>  Cell-to-cell signalling and interaction</td>
   <td>6.18E− 03 to 1.99E− 14</td>
   <td>100</td>
  </tr>
  <tr>
   <td>  Cell death and survival</td>
   <td>7.09E− 03 to 3.79E− 10</td>
   <td>97</td>
  </tr>
  <tr>
   <td>  Cellular movement</td>
   <td>6.44E− 03 to 4.26E− 10</td>
   <td>55</td>
  </tr>
  <tr>
   <td>  Cellular development</td>
   <td>6.48E− 03 to 5.54E− 10</td>
   <td>49</td>
  </tr>
  <tr>
   <td>  Cellular growth and proliferation</td>
   <td>6.18E− 03 to 5.54E− 10</td>
   <td>84</td>
  </tr>
  <tr>
   <td colspan="3">Top physiological system development and function</td>
  </tr>
  <tr>
   <td> Name</td>
   <td>
    <i>p</i> value 
   </td>
   <td>Molecules</td>
  </tr>
  <tr>
   <td>  Haematological system development and function</td>
   <td>6.48E− 03 to 6.44E− 13</td>
   <td>72</td>
  </tr>
  <tr>
   <td>  Immune cell trafficking</td>
   <td>6.18E− 03 to 6.44E− 13</td>
   <td>47</td>
  </tr>
  <tr>
   <td>  Embryonic development</td>
   <td>1.86E− 05 to 1.86E− 05</td>
   <td>4</td>
  </tr>
  <tr>
   <td>  Haematopoiesis</td>
   <td>6.48E− 03 to 2.86E− 05</td>
   <td>24</td>
  </tr>
  <tr>
   <td>  Hair and skin development and function</td>
   <td>6.18E− 03 to 4.26E− 05</td>
   <td>10</td>
  </tr>
 </tbody>
 <tfoot>
  <p>The differentially expressed genes in adalimumab good-responders (baseline versus 3 months) were analysed using Ingenuity Pathway Analysis (IPA) software. The top associated terms for the output themes, which were either up- or downregulated, are presented with associated 
   <i>p</i> values. The table also displays the number of molecules, or the number of differentially expressed transcripts within the dataset associated with each term 
  </p>
 </tfoot>
</table>
